A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression.
about
Novel progesterone receptors: neural localization and possible functionsThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmMifepristone modulates serotonin transporter functionAn exploration of testosterone levels in patients with bipolar disorder.All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.The management of cognitive impairment in bipolar disorder: current status and perspectives.Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individualsDouble-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol.Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.Childhood trauma in bipolar disorder.A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses.Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans.Adeno-associated Virus-mediated, Mifepristone-regulated Transgene Expression in the Brain.Mind and body: how the health of the body impacts on neuropsychiatry.RU486 Mitigates Hippocampal Pathology Following Status Epilepticus.Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.Inflammatory mediators of cognitive impairment in bipolar disorder.Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.Drugs under early investigation for the treatment of bipolar disorder.Issues encountered in recent attempts to develop novel antidepressant agents.Cortisol levels in fingernails, neurocognitive performance and clinical variables in euthymic bipolar I disorder.Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionFootshock-induced plasticity of GABAB signalling in the lateral habenula requires dopamine and glucocorticoid receptors.Neurocognitive functioning in bipolar depression: a component structure analysis.Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis via Regulating the Sensitivity of Glucocorticoid Receptor.Association between cortisol awakening response and memory function in major depression.Fractionation of visuo-spatial memory processes in bipolar depression: a cognitive scaffolding account.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
P2860
Q21129360-EEAC2261-3EC8-4786-9DD7-B755800BE0CCQ28066714-193D7D1D-B78E-4700-9E0E-AAB65C83DD4EQ28247599-8E7FEC15-7AB2-459C-B005-43D8AA00BEA8Q30490010-7A35DF4C-38DC-4BA7-8EE3-6E83A0936EA6Q30578605-B0933855-860D-4988-967A-BF480A608E21Q34067068-EC5667B8-8D2F-4137-A3F3-411D77B21587Q35582604-0980AE09-A9CC-4B64-B7C3-FCBCFB8BF639Q35647316-8CE841F4-11EA-46BB-B40F-F8D4CAE26602Q35934883-D656EA42-7EC2-4966-A550-0C203BB6DB61Q35950801-0DA39E63-C3F8-4663-A5AD-347A7AE5F234Q35964180-C6152340-D4D2-46FF-8D35-D45EE9CCC589Q36744851-132226F6-0925-472B-A412-03CAE4A0CDE8Q36901146-B6762680-4F94-495B-883A-EB26B42FC24CQ37065552-EBB23DF2-1A37-408C-B368-D4C30A0119D7Q37399776-50AE37C1-4F91-4211-A8F6-64836C3C443BQ37443907-6310B865-F5A9-483B-8260-2E3F65E477EEQ38203227-3EE40086-6FC6-4A2E-AED9-9CA0957F174DQ38215023-C48365D7-EC90-4E04-99CF-C775E4B26D69Q38220580-3EE34ECD-7D32-49B3-B9E2-0E404B4F1E44Q38364032-67485B72-7133-440C-B5C8-45C9135E1120Q38374429-8DD6802F-F57E-4769-930A-E44EB1022E82Q38739353-6F5C707B-7C3F-4BF0-BE4C-694E20D54C32Q38789179-CE2D63EB-9062-4789-BFD9-71A09D4218C4Q38990885-64D9D2C9-6A20-4CE5-91D2-3923D7318610Q39175146-59AEB579-A2DE-421B-A90A-A4C3E5259FB0Q39396568-0B051A9F-75CB-4346-BFDF-E0B77F869C69Q47609337-FD4A8E1E-D521-4A0D-8F32-C8C0BBC9C5FCQ48148070-A7B8746A-A3D0-4DA2-8DD8-3E4110D5C9A6Q48246484-CFBA955D-8C6D-4EED-92A5-84E606599F55Q52656684-68E3F424-A034-46BD-829B-5E638939A74AQ58698095-718BE7E1-7AF1-42D7-89B0-B74DDFCD1FEE
P2860
A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A randomized trial to examine ...... ients with bipolar depression.
@ast
A randomized trial to examine ...... ients with bipolar depression.
@en
A randomized trial to examine ...... ients with bipolar depression.
@nl
type
label
A randomized trial to examine ...... ients with bipolar depression.
@ast
A randomized trial to examine ...... ients with bipolar depression.
@en
A randomized trial to examine ...... ients with bipolar depression.
@nl
prefLabel
A randomized trial to examine ...... ients with bipolar depression.
@ast
A randomized trial to examine ...... ients with bipolar depression.
@en
A randomized trial to examine ...... ients with bipolar depression.
@nl
P2093
P1476
A randomized trial to examine ...... ients with bipolar depression.
@en
P2093
Allan H Young
I Nicol Ferrier
Lisa J Herron
Margaret S Smith
North-East Mood Disorders Clinical Research Group
Richard J Porter
Samantha Bulmer
P304
P356
10.1016/J.BIOPSYCH.2012.05.029
P407
P577
2012-07-07T00:00:00Z